IL37 and psoriasis: These substances have demonstrated the ability to suppress dendritic cell activation and reduce the secretion of pro-inflammatory cytokines, including IL-12 and IL-23, which are crucial in the pathogenesis of psoriasis (Halim et al. 2020).